<SEC-DOCUMENT>0001104659-22-071898-index.html : 20220616
<SEC-HEADER>0001104659-22-071898.hdr.sgml : 20220616
<ACCEPTANCE-DATETIME>20220616161153
ACCESSION NUMBER:		0001104659-22-071898
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20220614
FILED AS OF DATE:		20220616
DATE AS OF CHANGE:		20220616

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Sems Lloyd
		CENTRAL INDEX KEY:			0001436850

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50626
		FILM NUMBER:		221020683

	MAIL ADDRESS:	
		STREET 1:		C/O SEMS CAPITAL
		STREET 2:		7 DEY STREET, SUITE 1101
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cyclacel Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001130166
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				911766850
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922
		BUSINESS PHONE:		908-517-7330

	MAIL ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XCYTE THERAPIES INC
		DATE OF NAME CHANGE:	20001218
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>tm2218645-4_4seq1.xml
<DESCRIPTION>OWNERSHIP DOCUMENT
<TEXT>
Document 1 - file: tm2218645-4_4seq1.html

Document 1 - RAW XML: tm2218645-4_4seq1.xml

</DOCUMENT>
</SEC-DOCUMENT>